BlackRock’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,947,917
| Closed | -$142M | – | 5643 |
|
|
2021
Q1 | $142M | Buy |
5,947,917
+324,340
| +6% | +$6.03M | ﹤0.01% | 1966 |
|
|
2020
Q4 | $82.1M | Buy |
5,623,577
+262,892
| +5% | +$3.48M | ﹤0.01% | 2195 |
|
|
2020
Q3 | $76.1M | Sell |
5,360,685
-46,704
| -0.9% | -$714K | ﹤0.01% | 2058 |
|
|
2020
Q2 | $79.5M | Buy |
5,407,389
+1,133,154
| +27% | +$11.5M | ﹤0.01% | 1988 |
|
|
2020
Q1 | $17.6M | Sell |
4,274,235
-15,592
| -0.4% | -$73.1K | ﹤0.01% | 2676 |
|
|
2019
Q4 | $20.6M | Buy |
4,289,827
+55,948
| +1% | +$309K | ﹤0.01% | 2863 |
|
|
2019
Q3 | $25.7M | Buy |
4,233,879
+424,702
| +11% | +$2.65M | ﹤0.01% | 2675 |
|
|
2019
Q2 | $24.7M | Buy |
3,809,177
+193,216
| +5% | +$1.36M | ﹤0.01% | 2732 |
|
|
2019
Q1 | $25.6M | Sell |
3,615,961
-22,371
| -0.6% | -$147K | ﹤0.01% | 2623 |
|
|
2018
Q4 | $17.7M | Buy |
3,638,332
+28,537
| +0.8% | +$149K | ﹤0.01% | 2791 |
|
|
2018
Q3 | $26.5M | Buy |
3,609,795
+251,078
| +7% | +$1.84M | ﹤0.01% | 2723 |
|
|
2018
Q2 | $21.4M | Buy |
3,358,717
+250,306
| +8% | +$1.65M | ﹤0.01% | 2814 |
|
|
2018
Q1 | $16.9M | Sell |
3,108,411
-14,001
| -0.4% | -$69.6K | ﹤0.01% | 2857 |
|
|
2017
Q4 | $13M | Sell |
3,122,412
-269,929
| -8% | -$1.62M | ﹤0.01% | 3013 |
|
|
2017
Q3 | $32.7M | Buy |
3,392,341
+334,734
| +11% | +$3.48M | ﹤0.01% | 2534 |
|
|
2017
Q2 | $36.2M | Buy |
3,057,607
+86,727
| +3% | +$1.11M | ﹤0.01% | 2449 |
|
|
2017
Q1 | $38.1M | Buy |
2,970,880
+2,967,818
| +96,924% | +$35.7M | ﹤0.01% | 2391 |
|
|
2016
Q4 | $38K | Sell |
3,062
-575
| -16% | -$6.83K | ﹤0.01% | 3057 |
|
|
2016
Q3 | $43K | Sell |
3,637
-800
| -18% | -$7.72K | ﹤0.01% | 3036 |
|
|
2016
Q2 | $39K | Buy |
4,437
+1,659
| +60% | +$11.4K | ﹤0.01% | 3050 |
|
|
2016
Q1 | $14K | Buy |
2,778
+1,742
| +168% | +$9.7K | ﹤0.01% | 3020 |
|
|
2015
Q4 | $8K | Hold |
1,036
| – | – | ﹤0.01% | 3005 |
|
|
2015
Q3 | $8K | Hold |
1,036
| – | – | ﹤0.01% | 2853 |
|
|
2015
Q2 | $9K | Hold |
1,036
| – | – | ﹤0.01% | 2888 |
|
|
2015
Q1 | $13K | Hold |
1,036
| – | – | ﹤0.01% | 2599 |
|
|
2014
Q4 | $14K | Hold |
1,036
| – | – | ﹤0.01% | 2569 |
|
|
2014
Q3 | $9K | Hold |
1,036
| – | – | ﹤0.01% | 2821 |
|
|
2014
Q2 | $14K | Buy |
1,036
+158
| +18% | +$1.65K | ﹤0.01% | 2582 |
|
|
2014
Q1 | $9K | Hold |
878
| – | – | ﹤0.01% | 2806 |
|
|
2013
Q4 | $12K | Buy |
878
+126
| +17% | +$1.53K | ﹤0.01% | 2628 |
|
|
2013
Q3 | $9K | Hold |
752
| – | – | ﹤0.01% | 2733 |
|
|
2013
Q2 | $8K | Buy |
+752
| New | +$10.4K | ﹤0.01% | 2799 |
|
BlackRock's GNMK Position: Q2 2021 in Review
BlackRock sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 5,947,917 shares — an estimated $142M sold.
BlackRock first reported a position in GNMK in Q2 2013 and held it in 32 quarters. The position peaked at $142M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- BlackRock reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- BlackRock sold 5,947,917 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $142M.
- BlackRock first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 32 quarters.
- BlackRock's GenMark Diagnostics, Inc position peaked at $142M in Q1 2021.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.